VisEn Medical, Inc.: Series B $12M

Posted in I - Series B, Q - 2Q08, R - NORTH EAST, X - Biomarker, X - Imaging, X - Reagent

VisEn Medical (Woburn, MA) commercial-stage company focused on fluorescence in vivo imaging, closed a $5M Series B financing. Participants include Merck Capital Ventures and Flagship Ventures.

Nov

2008

Progentech Limited, Inc.: Series C $21M

Posted in I - Series C, Q - 2Q08, R - WEST, X - Reagent

Progentech Limited (Emeryville, CA) a commercialization-stage developer of instrumentation to purify and analyze proteins, DNA, and RNA, closed a $21M Series C financing. Participants include Bay City Capital and DT Capital.

Nov

2008

Codon Devices, Inc.: Series B $31M

Posted in I - Series B, Q - 1Q08, R - NORTH EAST, X - Reagent

Codon Devices (Cambridge, MA) constructive biology platform company incorporating informatics, robotics and sequencing technologies to synthesize genetic codes more rapidly and cost-effectively, closed a $31M Series B financing. Participants include Highland Capital Partners, Alloy Ventures, Flagship Ventures, Khosla Ventures, Tactics II Ventures and Kleiner Perkins Caufield & Byers.

Next Entries »

to top of page...